Fertility Patient Advances Bulk of Genetic Testing False-Ad Suit

Reproductive Genetic Innovations Inc., an assisted reproductive technology company, failed to convince a federal judge to wholly toss a proposed class action alleging it misleads in-vitro fertilization patients about the accuracy of a chromosomal abnormality test.

The US District Court for the Northern District of Illinois allowed breach of warranty and fraud claims as well as a claim under the Illinois Consumer Fraud and Deceptive Business Practices Act to proceed Wednesday. But the court cut a claim under the Uniform Deceptive Trade Practices Act.

Plaintiff Noelia Donamaria alleged RGI advertised its preimplantation genetic testing for aneuploidy as a proven, accurate, ...